Minerals Technologies heads into its July 31 Q2 earnings report with one striking divergence from the cautious pre-earnings tone that typically surrounds specialty chemical names: options traders have shifted sharply toward calls.
The clearest signal into the print is what the options market is NOT doing. The put/call ratio has dropped to 0.61, more than 2.6 standard deviations below its 20-day average of 0.97. For a stock that spent most of the past six weeks with PCR running comfortably above 1.0 — tilted toward puts — that move is abrupt and material. It marks the most call-heavy posture the options market has taken on MTX in recent memory, landing near the annual low end of the PCR range. The stock itself has pulled back 6.4% over the past month to $72.51, losing another 1.7% on Wednesday, which makes the swing toward calls all the more notable — investors are reaching for upside even as price drifts lower.
Short interest tells a less alarming story, though it is moving in one direction. Bears have added exposure over the past month at a meaningful pace — short interest has climbed roughly 70% from late June lows, reaching 2.4% of the free float. That sounds dramatic, but the raw level remains modest. Borrow conditions confirm this: availability is extraordinarily loose at 3,418%, meaning tens of millions of shares remain available to lend. Cost to borrow spiked briefly above 2.6% mid-week but has settled back to 1.24%, still well above the ~0.45% level that prevailed through most of June and July. The lending market is not stressed — the short build looks opportunistic rather than structural.
The bull-bear debate on MTX centres on whether a patchy demand recovery across its two main segments can translate into margin improvement. Bulls point to improving order patterns in Household & Personal Care and growing interest in the company's PFAS remediation product, which has been accumulating project wins in North America and Europe. Bears counter with a 10% year-over-year sales decline in Consumer & Specialties — driven by automotive sealant weakness, pet care destocking, and paper/packaging outages — alongside a 6% drop in Engineered Solutions. The most recent analyst coverage from Truist Securities, which raised its target to $90 in early May while maintaining a Buy, sits well above the current price. The consensus mean target of $94.25 implies roughly 30% upside from here. The valuation setup supports the bull case on paper: the stock trades at around 10.7x earnings and 7.1x EV/EBITDA, with both multiples compressing over the past month as the share price has fallen. The EV/EBITDA multiple has drifted lower by about 0.14 turns over 30 days — a modest re-rating that could sharpen the recovery trade if earnings deliver.
On the ownership side, Fidelity (FMR LLC) reported a substantial addition of 1.54 million shares through June, bringing its stake to 13.8% of the company — the largest reported change among major holders. That is a meaningful conviction move from a large institutional name heading into the print. CEO Douglas Dietrich sold $1.76 million of stock in May at $81.53, which is worth noting given the stock now trades nearly 11% below that level.
The print will test whether the demand recovery in Consumer & Specialties is broad enough and durable enough to justify the call-buying surge that arrived just as the stock slipped to its weakest levels in months — and whether Fidelity's bet on a rebound has found its catalyst.
See the live data behind this article on ORTEX.
Open MTX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
